Clinical Trial: A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting Elafibranor

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906639) titled 'A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting Elafibranor' on Oct. 07.

Brief Summary: The purpose of this study is to understand how tiredness changes in adults with Primary Biliary Cholangitis (PBC) after starting elafibranor in routine clinical practice.

PBC is a rare liver disease that damages the small bile ducts in the liver.

Participants will complete questionnaires before starting elafibranor and at Months 3, 6 and 12. The questionnaires will ask about tiredness, itching, work and daily activities. Each participant will be followed for approximately 12 months.

Study St...